DARE BIOSCIENCE INC (DARE) Earnings History & Surprises

NASDAQ:DAREUS23666P2002

Current stock price

1.74 USD
-0.16 (-8.42%)
At close:
1.83 USD
+0.09 (+5.17%)
After Hours:

DARE Earnings overview

Past quarterly earnings results for DARE BIOSCIENCE INC (DARE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
1.607M

Last Reported

Most Recent
Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Reported
-$0.02
EPS Surprise
95.47%
Revenue Surprise
167.18%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.02 -0.44 95.47% 96.92% 1.024M 383.265K 167.18% 1,700.00%
Q3 2025 -0.28 -0.36 23.04% 49.09% 2K 9.945K -79.89% -
Q2 2025 -0.45 -0.59 23.94% -129.61% -21K 192.443K -110.91% -195.45%
Q1 2025 -0.50 -0.59 15.48% 40.48% 25.43K 306K -91.69% 182.56%
Q4 2024 -0.65 -0.54 -19.49% 9.72% -64K 1.36M -104.71% -103.54%
Q3 2024 -0.55 -0.75 26.47% 49.07% 41.7K 4.127M -100.00% -100.00%
Q2 2024 1.52 0.00 - 226.67% 22K 8.013M -99.73% -
Q1 2024 -0.84 -0.73 -14.38% 22.22% 9K 265.71K -96.61% -
Q4 2023 -0.72 -1.20 39.98% 68.42% 1.808M 1.875M -3.57% -
Q3 2023 -1.08 -1.20 9.96% -12.50% 1M 440.028K 127.26% -
Q2 2023 -1.20 -1.20 0.30% - 747.997K -100.00% -100.00%
Q1 2023 -1.08 -1.22 11.76% 10.00% 1.7M -100.00% -
Q4 2022 -2.28 -1.67 -36.30% -5.56% - -
Q3 2022 -0.96 -1.44 33.25% 55.56% 2.03M -100.00% -
Q2 2022 0.00 -0.78 100.00% 100.00% 10M 10.2M -1.96% -
Q1 2022 -1.20 -1.74 31.20% 41.18% 370.005K -100.00% -
Q4 2021 -2.16 -1.79 -20.87% 35.71% 1.275M -100.00% -
Q3 2021 -2.16 -1.62 -33.19% 25.00% 2.92M -100.00% -
Q2 2021 -2.16 -1.93 -12.04% 33.33% - -
Q1 2021 -2.04 -2.72 25.09% 5.56% - -
Q4 2020 -3.36 -1.54 -117.86% - 530.4K -100.00% -
Q3 2020 -2.88 -2.08 -38.41% - 186.252K -100.00% -
Q2 2020 -3.24 -1.86 -74.15% - 212.415K -100.00% -
Q1 2020 -2.16 -3.61 40.18% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

DARE EPS Q2Q GrowthDARE EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 0 200 -200 -400

Revenue Historical Q2Q growth and Acceleration

DARE Revenue Q2Q GrowthDARE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/23 Q3/24 Q4/24 Q1/25 Q2/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 200K 400K 600K 800K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
10.74%
Max EPS beat (4)
23.94%
Min EPS beat (4)
-19.49%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-96.80%
Max Revenue beat (4)
-79.89%
Min Revenue beat (4)
-110.91%

Analysis

In the last 4 quarters, DARE has beaten EPS estimates in 3 out of 4 releases
DARE has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, DARE has beaten the EPS estimates by 10.7% on average.
In the last 4 quarters, DARE reported -96.8% below the revenue estimates on average.

DARE BIOSCIENCE INC / DARE Earnings FAQ

Can you provide the last earnings date for DARE BIOSCIENCE INC?

DARE BIOSCIENCE INC (DARE) last reported earnings on 3/26/2026.

Can you provide information on whether DARE BIOSCIENCE INC beat earnings estimates in the last quarter?

DARE BIOSCIENCE INC (DARE) beat EPS estimates and beat revenue estimates in the most recent quarter.

What percentage of the time does DARE stock beat earnings estimates?

In the last 4 quarters, DARE BIOSCIENCE INC (DARE) has beaten EPS estimates in 3 out of 4 releases.